Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Campone

Showing results (71-80 of 302) with videos related to

Pageof 31
Sort By:
Expert Opinion on Pharmacotherapy|November 25, 2017
Efficacy of buparlisib in treating breast cancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Proteomics|July 19, 2019
OLFM4 Expression in Ductal Carcinoma In Situ and in Invasive Breast Cancer Cohorts by a SWATH-Based Proteomic ApproachIsabelle Valo, Pedro Raro, Alice Boissard, et al.
Clinical Biochemistry|June 5, 2012
Paraoxonase 1 (PON1) as a marker of short term death in breast cancer recurrenceChristine Bobin-Dubigeon, Isabelle Jaffré, Marie-Pierre Joalland, et al.
Drugs|August 26, 2018
An Update on the Clinical Use of CDK4/6 Inhibitors in Breast CancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Environmental Science & Technology|September 30, 2025
Blood Sample Preparation for Human Chemical Exposomics: Insights from Large-Scale ApplicationsJade Chaker, Eva Gorrochategui Matas, Cécile Chevrier, et al.
JCO Clinical Cancer Informatics|February 18, 2026
Development and Assessment of a Pipeline for Extracting Structured Data From Free-Text Medical Reports Using a Large Language ModelEnzo Joseph, Paul Vallee, Tanguy Perennec, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 23, 2018
Pharmacokinetic drug evaluation of abemaciclib for advanced breast cancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Breast Cancer Research and Treatment|November 1, 2017
Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factorsFrédérique Nguyen, Laura Peña, Catherine Ibisch, et al.
Expert Review of Anticancer Therapy|March 20, 2019
Pertuzumab for the treatment of breast cancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 11, 2011
FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patientsCaroline Rousseau, Anne Devillers, Mario Campone, et al.
Pageof 31

Showing results (71-80 of 302) with videos related to

Sort By:
Pageof 31
Expert Opinion on Pharmacotherapy|November 25, 2017
Efficacy of buparlisib in treating breast cancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Proteomics|July 19, 2019
OLFM4 Expression in Ductal Carcinoma In Situ and in Invasive Breast Cancer Cohorts by a SWATH-Based Proteomic ApproachIsabelle Valo, Pedro Raro, Alice Boissard, et al.
Clinical Biochemistry|June 5, 2012
Paraoxonase 1 (PON1) as a marker of short term death in breast cancer recurrenceChristine Bobin-Dubigeon, Isabelle Jaffré, Marie-Pierre Joalland, et al.
Drugs|August 26, 2018
An Update on the Clinical Use of CDK4/6 Inhibitors in Breast CancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Environmental Science & Technology|September 30, 2025
Blood Sample Preparation for Human Chemical Exposomics: Insights from Large-Scale ApplicationsJade Chaker, Eva Gorrochategui Matas, Cécile Chevrier, et al.
JCO Clinical Cancer Informatics|February 18, 2026
Development and Assessment of a Pipeline for Extracting Structured Data From Free-Text Medical Reports Using a Large Language ModelEnzo Joseph, Paul Vallee, Tanguy Perennec, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 23, 2018
Pharmacokinetic drug evaluation of abemaciclib for advanced breast cancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Breast Cancer Research and Treatment|November 1, 2017
Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factorsFrédérique Nguyen, Laura Peña, Catherine Ibisch, et al.
Expert Review of Anticancer Therapy|March 20, 2019
Pertuzumab for the treatment of breast cancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 11, 2011
FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patientsCaroline Rousseau, Anne Devillers, Mario Campone, et al.
Pageof 31